A comprehensive playbook for identifying, positioning for, and profiting from contractions in private credit, CLO, and leveraged loan markets. Instruments, strategies, catalysts, and the complete methodology for building actionable drawdown analysis.
Private credit markets have accumulated $1.7T in AUM at cycle-peak leverage, covenant-lite structures, and opaque marks. Default rates are accelerating. CLO formation — the marginal buyer of 70% of leveraged loans — is vulnerable to equity distribution declines. The conditions for a 2020-scale or larger drawdown are present.
Late Phase 1 / Early Phase 2. Distress ratio at 7.2% (highest since late 2022). OXLC cut distribution 50%. Blue Owl gating withdrawals. Alt managers down 39-61% from highs. CLO equity stress is no longer theoretical — it's here. The positioning window is narrowing but still open for options-based structures.
Initiate 70-80% of target bearish allocation immediately. Phase 2 signals are emerging — Blue Owl gates, OXLC distribution cuts, alt manager drawdowns. Favor zero-cost structures (risk reversals, ratio spreads) and positive-carry trades (CLO tranche, SOFR strip). Reserve 20-30% for Phase 2 full confirmation.
The economy holds. If GDP growth stays above 2%, unemployment stays below 4.5%, and the Fed cuts proactively, defaults plateau at 4-5% and the cycle extends. In this scenario, the portfolio bleeds ~2.5% over 12 months — manageable given asymmetric upside.
This is the best risk/reward setup for a private credit drawdown hedge since Q4 2019. Carry costs are at cycle lows. Vol is structurally cheap. The structural vulnerabilities (covenant-lite, mark-to-market lag, CLO formation dependency) are at all-time extremes. You don't need to predict the catalyst — you need to be positioned before it arrives. The 10 trade structures in this document cost 150bps/quarter to maintain and generate 35-65% returns in a severe-stress scenario. The payoff asymmetry — 10:1 max stress return vs. max thesis-wrong loss — justifies the position today.
Live dashboard of the key indicators driving the drawdown thesis. Each metric is color-coded against the monitoring framework thresholds (Section 09). Updated with each edition.
Dashboard Reading: 4 of 13 indicators are Green. 4 are Yellow. 5 are Red. This is a decisive shift from the prior edition. The distress ratio at 7.2%, OXLC distribution cuts, Blue Owl gating withdrawals, and alt manager stocks down 39-61% confirm that Phase 1 is ending and Phase 2 (Acceleration) is beginning. The critical divergence: CLO issuance remains healthy ($17B/month) while the underlying credit quality is collapsing (7.2% distress ratio). This exact divergence — healthy market plumbing with deteriorating fundamentals — preceded the March 2020 drawdown by ~3 months. The window for cheap positioning is closing. Vol will reprice within weeks once the CLO issuance slowdown begins.
Current conditions mapped against the four major credit stress periods. The "Today" row shows where current indicators stand relative to pre-drawdown readings.
| Indicator | Pre-2008 (Jun '07) | Pre-2016 (Jun '15) | Pre-2020 (Jan '20) | Pre-2022 (Dec '21) | Today (Apr '26) |
|---|---|---|---|---|---|
| LL Default Rate | 1.5% | 2.1% | 1.6% | 0.5% | 3.8% |
| HY OAS | 260bps | 480bps | 340bps | 280bps | ~300bps |
| Cov-Lite Share | 25% | 64% | 82% | 86% | 89% |
| Private Credit AUM | $120B | $480B | $850B | $1.2T | $1.7T+ |
| CLO Outstanding | $350B | $420B | $650B | $850B | $1.1T |
| Avg. Leverage (LBO) | 5.4x | 5.8x | 5.7x | 6.2x | 6.5x |
| Peak-to-Trough (Loan Index) | → -38% | → -8% | → -24% | → -7% | TBD |
| Peak-to-Trough (BDC Sector) | → -70% | → -25% | → -55% | → -18% | TBD |
| Recovery Time to Par | 36 months | 8 months | 12 months | 6 months | — |
| Closest Historical Analog | ← comparison basis → | Late 2019 structure, with 2x the AUM and higher leverage | |||
Reading the Table: The "Today" column shows that the structural vulnerabilities (covenant-lite share, AUM, leverage, CLO size) are at all-time extremes — worse than any prior pre-drawdown period. But the market stress indicators (OAS spreads, loan prices) are still benign. This is the classic "pre-drawdown divergence" — structural risk has accumulated but hasn't yet been reflected in market prices. The 2019 analog is the closest match: benign market pricing masking rising defaults. That divergence resolved in March 2020 with a 24% loan drawdown and 55% BDC drawdown in 5 weeks.
Different readers need different sections. Route to your priority path below.
You need the thesis, the risk/reward math, and the portfolio construction framework. Skip individual trade structures.
You need the full strategy set, the correlation matrix, and the entry/exit triggers to build your own book.
You need Greeks, P&L scenarios, contract specs, and execution mechanics. Start with futures overlay, then deep-dive on 3-4 core strategies.
You need everything. Read end-to-end. Pay special attention to the methodology and verification sources for replication.
Understanding the interconnected layers of private credit markets is essential before positioning for a drawdown. Capital flows down this stack; stress flows up.
The single most important structural fact: CLOs hold ~70% of all U.S. leveraged loans. When CLO formation slows — because equity tranche returns decline — the marginal buyer of the entire leveraged loan market steps back. Every instrument in this section is downstream of that one dynamic.
These are the liquid, tradeable instruments through which investors can express a bearish view on private credit markets. Organized by directness of exposure and liquidity.
Highest conviction, most direct exposure to private credit drawdowns. Require options approval or short-selling capability.
Institutional-grade instruments. Require ISDA documentation and a derivatives counterparty. The purest expression of credit spread widening.
Broader credit-sensitive instruments that benefit from private credit stress but also carry other factor exposures.
Strategies for deploying capital after the drawdown occurs. The biggest returns in credit come from buying distressed assets at dislocated prices.
Institutional-grade trade structures with specific Greeks, carry analysis, P&L scenarios, and execution mechanics. Each strategy is sized for a $50M risk book. Scale linearly. Structures assume current market levels as of April 2026.
Why now, specifically: HYG implied vol is 6.2% — bottom quintile historically. CDX HY spreads at 350bps are 40th percentile — asymmetric to the wide side. BDC risk reversals can be entered at zero cost. The carry budget for this entire portfolio is 150bps/quarter. In 18 months, if we enter Phase 2, every one of these structures will cost 2-3x more to initiate. The window for cheap positioning is open. It will not stay open.
Desk-Level Framing: These are not "ideas" — they are trade structures with defined entry, carry, Greeks, exit, and loss budget. Every position has a maximum acceptable loss expressed as a percentage of the total risk book. The aggregate portfolio carry is budgeted at 150-200bps/quarter. If you cannot articulate the exact scenario in which a position loses its maximum and the mechanism by which you will exit, the position is not sized — it is a guess.
Long 1x ATM put, short 2x 8% OTM puts on HYG. 6-month expiry. This structure is net zero or slight credit at entry, convex through the -3% to -15% range, and capped below -16%. The ratio spread exploits HYG's structurally cheap skew — implied vol on OTM puts is too low relative to realized tail risk. HYG options are the deepest credit derivatives market in existence (150K+ contracts/day). You can execute $20M notional without moving the market 1bp.
| HYG Price | OAS Implied | Move | Spread P&L | 100-Lot P&L | Scenario |
|---|---|---|---|---|---|
| $78 | ~270bps | +2.6% | -$0.15 | -$1,500 | Spread compression — thesis wrong |
| $76 | ~300bps | 0% | -$0.10 | -$1,000 | Unchanged — time decay eats small debit |
| $73 | ~400bps | -3.9% | +$2.90 | +$29,000 | Moderate stress — 2022 level |
| $70 | ~520bps | -7.9% | +$5.85 | +$58,500 | Max profit zone — severe stress |
| $66 | ~700bps | -13.2% | +$1.85 | +$18,500 | Past max — short puts eating into gains |
| $60 | ~950bps | -21.1% | -$4.15 | -$41,500 | Crash — need wing or stop (add $64P) |
Sell OTM call spreads on ARCC to fund OTM puts. The risk reversal exploits BDC-specific dynamics: dividend yield caps upside (limiting call risk), while NAV markdown risk creates fat left tails. ARCC's 9.8% yield means the stock rarely rallies more than 10% — but it fell 48% peak-to-trough in March 2020. The asymmetry is structural. Call premium finances the put — net zero or slight credit entry.
| ARCC Price | Scenario | P&L | 100-Lot P&L |
|---|---|---|---|
| $25+ | BDC sector rally (thesis wrong) | -$1.95 | -$19,500 |
| $23 | Mild rally | +$0.05 | +$500 |
| $19-$23 | Range-bound | +$0.05 | +$500 |
| $17 | Moderate stress (-21%) | +$2.05 | +$20,500 |
| $14 | Severe stress (2020-level, -35%) | +$5.05 | +$50,500 |
| $11 | Capitulation (-49%) | +$8.05 | +$80,500 |
Buy CDX HY protection (350bps running) and sell LCDX protection (200bps running) for a net carry cost of ~150bps/year. The thesis: in a downturn, recovery rate assumptions diverge violently. CDX HY assumes 40% recovery; LCDX assumes 70%. Historically, when defaults spike, actual loan recoveries compress toward 50-55% while bond recoveries fall to 30-35%. The LCDX recovery assumption is optimistic at cycle peaks. The basis widens as the market reprices this divergence. This is a negative-beta, positive-carry-adjusted trade that isolates recovery rate mispricing rather than directional spread movement.
| Scenario | CDX HY | LCDX | Basis Change | Net P&L |
|---|---|---|---|---|
| Benign — spreads compress | 300bps (-50) | 170bps (-30) | -20bps | -$170K (carry + basis) |
| Unchanged | 350bps | 200bps | 0bps | -$150K (carry only) |
| Moderate stress | 550bps (+200) | 300bps (+100) | +100bps | +$250K |
| Severe stress (2020-type) | 900bps (+550) | 450bps (+250) | +300bps | +$1.05M |
| Crisis (2008-type) | 1400bps (+1050) | 600bps (+400) | +650bps | +$2.6M |
Buy 6-month BKLN puts, sell 3-month BKLN puts at the same strike. The calendar spread exploits term structure: near-dated implied vol is depressed (carry-seeking sellers dominate short-dated options), while longer-dated vol is closer to fair value. During stress, the term structure inverts — near-dated vol spikes above long-dated — and you profit from both vega expansion and the structural ETF-to-NAV basis dislocation. BKLN's T+1 settlement vs. T+10 underlying loans means the ETF mechanically overshoots during outflows.
Dollar-neutral pair: long $1 BX vs. short $0.50 ARES + $0.50 OWL. Blackstone derives ~30% of AUM from credit, with the remainder in real estate, PE, insurance, and multi-asset. Ares derives ~65% from credit; Blue Owl ~80%. In a private credit drawdown, the credit-concentrated managers suffer disproportionate (1) performance fee declines, (2) AUM outflows, (3) fundraising headwinds, and (4) co-investment write-downs. BX's diversification provides relative insulation. The basket short reduces single-name idiosyncratic risk vs. shorting ARES alone.
| Scenario | BX Move | ARES/OWL Basket | Pair P&L |
|---|---|---|---|
| Risk-on rally (thesis wrong) | +15% | +20% | -$5,000 |
| Benign — flat markets | 0% | 0% | -$1,700 (carry) |
| Credit wobble (OAS +100bps) | -8% | -15% | +$7,000 |
| Credit stress (OAS +250bps) | -18% | -35% | +$17,000 |
| Full drawdown (2020-type) | -30% | -52% | +$22,000 |
Long JAAA (CLO AAA tranches) vs. short JBBB (CLO BBB tranches). This is a capital structure arbitrage within the same CLO collateral pool. AAA tranches have 35%+ subordination and have never experienced a principal loss in CLO history. BBB tranches have ~12% subordination and are the first rated tranche to experience OC test failure cash flow diversion. In a drawdown, JAAA barely moves (-1 to -3%) while JBBB drops -15 to -28%. The spread between AAA and mezzanine widens violently. Positive carry: JBBB short borrow cost is offset by the JAAA/JBBB yield differential.
| Scenario | JAAA | JBBB | Pair P&L | Annualized |
|---|---|---|---|---|
| Spread compression (wrong) | +1% | +4% | -$15,000 | Depends on holding period |
| Unchanged (carry only) | 0% | 0% | +$2,500 | +50bps (carry) |
| OC tests begin failing | -1% | -12% | +$55,000 | +11% on capital |
| Severe stress (2020-type) | -3% | -24% | +$105,000 | +21% on capital |
| Systemic crisis (2008-type) | -8% | -40% | +$160,000 | +32% on capital |
Buy variance on CDX HY spread movements via a variance swap or synthetic replication through a strip of CDX HY swaptions. This is the most convex position in the book — you don't need to be right on direction, only on magnitude. Credit spread variance is structurally underpriced because carry investors are net sellers of vol (they write covered calls, sell swaptions for yield enhancement). In every credit cycle, realized variance has exceeded implied by 3-8x during the stress period. The payoff function is quadratic in spread movement — 2x the move = 4x the P&L.
Long 10% OTM TLT 6-month calls + long 8% OTM HYG 6-month puts + long 5% OTM BKLN 6-month puts. In a recessionary credit drawdown, Treasuries rally (flight to safety, rate cuts) while credit sells off. Both legs profit simultaneously — "dual convexity." The TLT call premium is partially funded by being further OTM (leveraging duration). The credit legs are split across fixed (HYG) and floating (BKLN) to capture both rate-sensitive and credit-pure components. Combined premium is 1.2-1.8% of total position notional.
Buy 5-year CDX HY protection and sell 3-year CDX HY protection. When the credit curve is flat or inverted (as it is now — markets pricing benign near-term), the steepener costs very little carry. When stress arrives, the curve steepens violently: near-term spreads spike (immediate default risk repriced), but far-dated spreads widen less (markets price recovery on the backside). The 5Y-3Y basis widens from ~20bps to 80-150bps during stress. This is carry-efficient because the 3Y short premium partially offsets the 5Y long premium.
When BDC stocks trade at 30-50% NAV discounts (March 2020: sector average 33% discount), the market is pricing a scenario worse than the worst realized credit losses in BDC history. At a 35% NAV discount, you are buying $1 of credit assets for $0.65 — and collecting a 15%+ yield on your purchase price even if the dividend is cut by 30%. The "double dip" profit: NAV stabilizes (+10-15%) AND the discount compresses to par (+35-50%). Combined total return: 80-150% within 12-18 months. This strategy requires the discipline to buy when every headline screams to sell.
Individual strategies are positions. This section is how they fit together. A $50M risk book allocated across these strategies, with correlation awareness, aggregate Greeks, and carry budgeting.
Core Principle: The portfolio should generate positive P&L in three scenarios: (1) gradual credit deterioration, (2) sharp credit shock, and (3) unchanged markets with carry harvesting. The only scenario that produces aggregate loss is a sustained credit rally with spread compression — which is the scenario where the rest of a balanced portfolio (equities, real assets) outperforms. This is a hedge book, not a directional bet. Budget carry: 150-200bps/quarter. Max drawdown tolerance: 5% of book.
Aggregate Portfolio Metrics (at Entry):
Total carry budget: ~150bps/quarter ($187.5K/quarter on $50M book) — sustainable for 4-6 quarters of "being early."
Maximum defined loss: ~6.3% of book ($3.15M) — if every position hits maximum loss simultaneously (highly unlikely; correlation < 1).
Expected loss in "thesis wrong" scenario (spread compression, -50bps OAS): ~2.5% ($1.25M) — manageable.
Expected P&L in moderate stress (+200bps OAS): +12-25% ($6-12.5M).
Expected P&L in severe stress (+500bps OAS): +35-65% ($17.5-32.5M) — non-linear payoff dominates.
Ratio of max stress P&L to max thesis-wrong loss: ~10:1 — the payoff asymmetry justifies the carry.
| HYG Ratio | BDC R/R | CDX Basis | BKLN Cal | Mgr Pair | CLO Tranche | Var Swap | Barbell | Steepener | |
|---|---|---|---|---|---|---|---|---|---|
| HYG Ratio | 1.00 | 0.72 | 0.48 | 0.68 | 0.55 | 0.58 | 0.35 | 0.65 | 0.42 |
| BDC R/R | 0.72 | 1.00 | 0.40 | 0.55 | 0.70 | 0.50 | 0.28 | 0.48 | 0.30 |
| CDX Basis | 0.48 | 0.40 | 1.00 | 0.52 | 0.25 | 0.55 | 0.30 | 0.28 | 0.65 |
| BKLN Cal | 0.68 | 0.55 | 0.52 | 1.00 | 0.45 | 0.62 | 0.38 | 0.55 | 0.48 |
| Mgr Pair | 0.55 | 0.70 | 0.25 | 0.45 | 1.00 | 0.40 | 0.20 | 0.30 | 0.18 |
| CLO Tranche | 0.58 | 0.50 | 0.55 | 0.62 | 0.40 | 1.00 | 0.35 | 0.42 | 0.50 |
| Var Swap | 0.35 | 0.28 | 0.30 | 0.38 | 0.20 | 0.35 | 1.00 | 0.25 | 0.22 |
| Barbell | 0.65 | 0.48 | 0.28 | 0.55 | 0.30 | 0.42 | 0.25 | 1.00 | 0.30 |
| Steepener | 0.42 | 0.30 | 0.65 | 0.48 | 0.18 | 0.50 | 0.22 | 0.30 | 1.00 |
Reading the Matrix: Average inter-strategy correlation is ~0.42 — meaningful diversification but not independence. The highest correlated pair is HYG Ratio / BDC Risk Reversal (0.72) — both are directional credit short via listed options. The lowest is Manager Pair / Steepener (0.18) — fundamentally different drivers (equity vs. CDS term structure). The Variance Swap has the lowest average correlation to the book (0.29) — it profits on magnitude, not direction, providing genuine diversification. Key risk: in a systemic event, all correlations converge toward 1.0 — but in that scenario, all positions are also deeply profitable. Correlation risk matters more in moderate-stress scenarios where some strategies work and others don't.
All figures scaled to a $50M risk book. Multiply/divide linearly for your book size.
| Strategy | Allocation | Notional | Max Loss | Carry/Qtr | Stress P&L | Acct. Req. |
|---|---|---|---|---|---|---|
| 01 — HYG Ratio Spread | 12% | $6M notional | $120K (0.24%) | -$18K | +$1.2M | Options Tier 3 |
| 02 — BDC Risk Reversal | 10% | $5M notional | $98K (0.20%) | +$2.5K | +$800K | Options Tier 3 |
| 03 — CDX/LCDX Basis | 10% | $10M per leg | $170K (0.34%) | -$37.5K | +$2.6M | ISDA + Dealer |
| 04 — BKLN Calendar | 8% | $4M notional | $80K (0.16%) | -$12K | +$600K | Options Tier 2 |
| 05 — Alt Mgr Pair | 10% | $5M per leg | $400K (0.80%) | -$21K | +$1.1M | Margin + Short |
| 06 — CLO Tranche | 10% | $5M per leg | $150K (0.30%) | +$6.25K | +$1.05M | Margin + Short |
| 07 — Credit Var Swap | 8% | $50K vega-not. | $100K (0.20%) | -$25K | +$1.4M | ISDA or Opts T3 |
| 08 — Rates/Credit Barbell | 7% | $3.5M notional | $106K (0.21%) | -$26.5K | +$1.05M | Options Tier 2 |
| 09 — CDX HY Steepener | 5% | $10M per leg | $100K (0.20%) | -$10K | +$750K | ISDA + Dealer |
| 10 — BDC Capitulation (reserve) | 20% | $10M (dry powder) | N/A (long only) | +dividends | +$3-5M | Cash / Margin |
| TOTAL | 100% | $1.32M (2.65%) | -$142K/qtr | +$12.5M (25%) |
Complete each item before initiating positions. Click to mark complete. Progress is tracked locally in your browser.
Futures and ETF arbitrage strategies that layer on top of the core book. Futures offer superior capital efficiency (10-15% initial margin vs. 50%+ for equities), near-24-hour liquidity, Section 1256 tax treatment (60/40), and zero borrow cost. ETF arbitrage exploits structural mispricings created by the creation/redemption mechanism during stress.
Why this overlay matters: The core strategies (Sections 03/03b) use options and CDS — instruments with time decay and carry cost. The futures and ETF arbitrage strategies below are either carry-neutral or carry-positive, and they provide continuous delta exposure without premium bleed. A $50M book using 30% futures overlay replaces ~40% of the options carry cost while maintaining equivalent notional exposure. For traders who live on the futures desk, these are the native instruments.
The key contracts for expressing credit drawdown views via futures. All CME/CBOT unless noted.
Replace or supplement the TLT call leg from Strategy 08 with long ZN (10Y) or ZB (30Y) Treasury futures. In a recessionary credit event, Treasuries rally as the Fed cuts rates and investors flee to safety. Futures are superior to TLT calls for this purpose: no premium decay, near-24-hour liquidity, 7:1 leverage via margin, Section 1256 tax treatment, and precise duration targeting. One ZB contract controls ~$122K notional for ~$4,400 margin — a 28:1 capital efficiency ratio vs. buying TLT outright.
| 10Y Yield Move | Scenario | ZB Approx. Move | P&L (50 contracts) |
|---|---|---|---|
| +50bps | Rates rise (stagflation — thesis wrong) | -6 pts | -$300,000 |
| Unchanged | Flat — carry neutral | 0 | $0 (margin earns interest) |
| -50bps | Growth scare — mild easing | +6 pts | +$300,000 |
| -100bps | Recession — Fed cuts 100bps | +13 pts | +$650,000 |
| -200bps | Crisis — emergency rate cuts (2020 analog) | +28 pts | +$1,400,000 |
Buy a SOFR futures strip (e.g., Dec 2026 through Jun 2027 contracts) to express the view that the Fed will cut rates more aggressively than currently priced. In a credit drawdown scenario, the Fed cuts to ease financial conditions — SOFR futures rally as the market prices deeper cuts. The strip structure gives you exposure across multiple meeting dates rather than a single-date bet. Each 25bp rate cut moves the relevant contract ~25 ticks ($62.50/tick × 25 = $1,562.50 per contract). The strip also functions as a natural hedge for the floating-rate borrower stress thesis: if SOFR drops, borrower stress eases, reducing default risk — so your SOFR longs offset losses on credit shorts in a "soft landing" scenario.
Tactical short ES futures as a cross-asset overlay during Phase 2+ of the drawdown cascade. Credit stress and equity drawdowns are correlated in recessions (HYG/SPY correlation: 0.7-0.85 during stress). A small ES short position (5-10% of book notional) captures the equity leg of a broad risk-off move. ES is the single most liquid instrument in the world — you can execute $500M notional without moving the market. Use as a tactical overlay when credit stress signals cross into equity markets, not as a core position from inception.
During stress, BKLN and SRLN trade at persistent discounts to their indicative NAV (iNAV) because authorized participants (APs) cannot redeem fast enough — underlying loans settle T+10 but the ETF settles T+1. In March 2020, BKLN traded at a 5.2% discount to NAV for 8 consecutive trading days. This basis is a pure structural arbitrage: the ETF is mathematically cheap relative to its holdings. The trade: buy BKLN/SRLN when the discount exceeds 2%, and sell when it reverts to par. The basis always reverts — the only question is timing (typically 2-6 weeks). This strategy has generated 15-30% annualized returns in every stress period since loan ETFs were created.
HYG and JNK both track "high-yield bonds" but use different indices (Markit iBoxx vs. Bloomberg). The composition divergence creates 50-150bp tracking error spreads that widen during stress when underlying liquidity dries up. Long the cheaper ETF, short the richer one. This is market-neutral — you have zero directional credit exposure. You earn the carry differential (HYG and JNK have different yields due to different portfolio compositions) plus the basis reversion. Stress amplifies the opportunity because different index rebalancing dates create temporary misalignments.
This is the ETF-accessible version of Strategy 06 (CLO Tranche Trade). Long JAAA (AAA CLO tranches, $16B AUM) vs. short JBBB (BBB CLO tranches, $1.2B AUM) — or extend to include short CLOZ (CLO equity, $400M AUM) for maximum convexity. All three ETFs hold tranches backed by the same CLO collateral pools, but they sit at different levels of the capital structure. AAA has 35%+ subordination; BBB has ~12%; equity absorbs first loss. During stress, JAAA barely moves while JBBB and CLOZ get crushed. The ETF structure adds a liquidity arbitrage layer on top of the structural subordination trade: JBBB and CLOZ are less liquid ETFs that gap wider during outflows.
| Scenario | JAAA | JBBB | CLOZ | Net P&L |
|---|---|---|---|---|
| Spread compression (wrong) | +1% | +4% | +8% | -$6,000 |
| Unchanged (carry) | 0% | 0% | 0% | +$1,200 (carry) |
| OC tests begin failing | -1% | -12% | -22% | +$21,000 |
| Severe stress (2020) | -3% | -24% | -45% | +$40,500 |
| Crisis (2008) | -8% | -40% | -65% | +$56,500 |
Closed-end funds (CEFs) that hold leveraged loans and high-yield bonds trade at persistent discounts to NAV — and those discounts blow out during stress. Unlike ETFs, CEFs have a fixed share count (no creation/redemption mechanism), so the discount is a pure measure of market sentiment vs. portfolio value. Key names: BGX (Blackstone Senior Floating Rate), FRA (BlackRock Floating Rate), JQC (Nuveen Credit), VTA (Invesco Senior Loan). In calm markets these trade at 3-8% discounts; in stress, discounts widen to 15-25%. Buy at wide discounts, sell when they compress. The CEFs also use 25-35% leverage — which amplifies both the yield (currently 10-13%) and the drawdown. The leveraged discount is the dislocation; the yield is the carry while you wait.
How each overlay strategy interacts with the core book (Strategies 01-10).
| Strategy | Replaces / Supplements | Carry Impact | Margin Efficiency | When to Deploy | Min. Account |
|---|---|---|---|---|---|
| F1 — ZB Long | Replaces TLT calls (Strat 08) | Saves ~180bps/yr | 28:1 leverage | From inception — core position | $25K (futures acct) |
| F2 — SOFR Strip | New — portfolio hedge | Zero carry (futures) | 125:1 leverage | From inception — broadens win condition | $25K (futures acct) |
| F3 — ES Short | New — cross-asset overlay | Margin earns 4.5% | 20:1 leverage | Phase 2+ only — tactical | $25K (futures acct) |
| E1 — Loan ETF NAV Arb | Supplements Strat 04 (BKLN) | Earns yield + basis | 1:1 (cash) | NAV discount > 2% (event-driven) | $10K (any brokerage) |
| E2 — HYG/JNK Basis | New — market-neutral | +20-40bps/yr carry | 2:1 (margin) | Always on; scale up in stress | $25K (margin acct) |
| E3 — CLO Tranche ETF | ETF version of Strat 06 | +30-50bps/yr carry | 2:1 (margin) | From inception — core position | $25K (margin acct) |
| E4 — Loan CEF Discount | ETF version of Strat 10/11 | 10-13% yield while waiting | 1:1 (cash) | Discount > 12% (post-drawdown) | $5K (any brokerage) |
Portfolio Impact of the Futures/Arb Overlay: Adding F1 (ZB) and F2 (SOFR strip) to the core book replaces ~$45K/quarter of options carry cost with zero-carry futures, reducing the total book carry from -$142K/quarter to approximately -$97K/quarter — a 32% reduction. The SOFR strip simultaneously broadens the win condition to include "Fed cuts but economy holds" scenarios where the core credit book would bleed. The ETF arb strategies (E1-E4) add 3-5% annualized alpha in calm markets and 15-30% during stress, funded by positive carry, with near-zero correlation to the directional credit thesis. The complete book — core (03/03b) + overlay (03c) — generates positive expected returns in 4 of 5 macro scenarios. The only losing scenario is sustained stagflation with tight labor markets, no Fed cuts, and no credit deterioration. Budget accordingly.
A private credit drawdown doesn't happen in isolation. These are the catalysts — in rough chronological order of likely appearance — that would cascade through the private credit stack.
The next credit downturn will not begin with a Lehman-style event. It will begin with a quarterly CLO trustee report showing OC test failures, a semi-liquid fund activating its redemption gate, and a BDC cutting its dividend. The stress will be invisible to most investors until it is unavoidable.
Key Insight: The most important leading indicator is CLO formation pace. When monthly CLO issuance drops below $10B (vs. ~$17B current run rate), the marginal buyer of leveraged loans is stepping back. Monitor: LCD (Leveraged Commentary & Data), CLO-i, JP Morgan CLO research, and BofA CLO Weekly.
A repeatable methodology for building accurate private credit drawdown analysis. Adapted from the Pre-IPO Guide Builder framework with credit-specific verification requirements.
Before writing a single word, build a verified fact sheet for the current state of private credit markets. Every number must trace to a named source with a date stamp.
Understand how capital flows through the private credit ecosystem and where stress transmits. This is the foundation for identifying which instruments will move first and most.
Build a real-time dashboard of the leading indicators that predict drawdowns. Each indicator should be sourced, timestamped, and compared to historical stress thresholds.
Present the bear case with rigor but also the counter-arguments. Sophisticated investors respect balanced analysis. Identify the specific vulnerabilities and the conditions under which the thesis fails.
For each strategy, provide specific instruments, entry triggers, position sizing, risk management, and exit criteria. No generic advice — every recommendation must be executable.
Every instrument has risks beyond the thesis direction. Document the ways each position can lose money even if the thesis is correct.
Different drawdown strategies have different tax treatment. Document the tax implications for each strategy type.
Walk through the exact steps to implement each strategy. Include account setup, order types, position monitoring, and adjustment triggers.
Before publishing, systematically verify every factual claim, every historical return cited, and every instrument specification.
Credit data changes daily. Every number, spread, and price must be date-stamped. Plan a weekly refresh cadence for this guide — not monthly like equity guides.
Every private credit drawdown guide should follow this section structure. Adapted from the Pre-IPO Guide Builder template with credit-specific requirements.
Every factual claim must trace back to a named source. These are the primary data sources for building accurate private credit drawdown analysis, ranked by reliability.
The benchmark for the leveraged loan market. Daily prices, default rates, new issue volume, and index composition. Accessed via LCD (Leveraged Commentary & Data) or Bloomberg (SPBDLLB Index). The single most important data source for this guide.
CLO-level data: tranche pricing, OC test results, CCC bucket levels, equity distributions, and manager performance. Intex is the institutional standard (expensive). CLO-i and Creditflux provide accessible alternatives. JP Morgan and BofA CLO research are excellent secondary sources.
Default rate tracking, recovery rate studies, credit rating migration data, and sector-level stress analysis. Moody's publishes monthly default reports. S&P Global's LCD provides real-time default tracking. Compare all three — methodologies differ.
10-Q and 10-K filings for all publicly traded BDCs. NAV per share, non-accrual rates, dividend coverage, leverage ratios, and portfolio composition. BDCs must report these quarterly. Also check: BDC Buzz, Seeking Alpha BDC coverage, and CEF/BDC ETF providers.
OAS spreads for high-yield bonds (ICE BofA US HY Index), leveraged loan yields, and investment-grade spreads. Available via FRED (free, delayed) or Bloomberg terminal (real-time). The ICE BofA HY OAS is the most cited credit spread metric globally.
Weekly and monthly credit strategy reports covering CLO markets, leveraged loans, high-yield, and private credit. JP Morgan's "Credit Strategy Weekly" and BofA's "CLO Weekly" are the institutional standards. Goldman's credit team publishes excellent private credit analysis.
Private credit fund AUM, performance, fundraising, and deal-level data. Preqin is the standard for private market data. PitchBook provides deal-level leveraged loan data. KBRA's Direct Lending Deals (DLD) database is the most granular source for private credit deal terms.
Weekly fund flow data for leveraged loan, high-yield, and credit ETFs/mutual funds. ICI (Investment Company Institute) publishes weekly. Bloomberg ETF flow tools provide real-time. EPFR Global is the institutional standard for granular flow data.
Fed Shared National Credit (SNC) review data, OCC leveraged lending guidance, and SEC BDC regulatory framework. The Fed's annual SNC review is a critical source for leveraged loan credit quality data. OCC guidance on leveraged lending risk management sets the regulatory backdrop.
These are the most common errors that undermine drawdown analysis credibility and lead to poorly timed or incorrectly sized positions.
The #1 killer of drawdown positions is not being wrong — it's being right but too early. A thesis that is correct on direction but wrong on timing by 12 months can lose 30-50% of invested capital through carry bleed alone. Every structure in this document is designed to minimize carry cost. But the discipline of position sizing — never more than 5% of total portfolio in drawdown hedges — is what separates the desks that survive being early from those that blow up waiting.
Private credit funds mark their books quarterly, often using internal models rather than market prices. A fund reporting 98 cents NAV may hold assets that would trade at 85-90 cents on the secondary market. Always compare reported NAVs against (a) secondary market transaction prices, (b) comparable public loan prices, and (c) recent BDC marks on similar credits. The lag between economic reality and reported marks is where both the risk and the opportunity live.
Bearish credit positions bleed capital: options decay (theta), CDS positions require annual premium payments (350bps+ on CDX HY), and short positions on BDCs require paying the dividend yield (9-12%). A thesis that is correct on direction but wrong on timing by 12 months can still lose 30-50% of invested capital. Always model the carry cost explicitly and budget for "being early."
In March 2020, the Fed's unprecedented decision to buy corporate bonds (including HY ETFs) compressed credit spreads by 400bps in six weeks. Positions that were profitable at peak stress gave back gains rapidly. Any drawdown thesis must model the Fed intervention scenario. Key question: does the Fed have the legal and political will to backstop private credit this time? (Short answer: maybe not — but they will backstop the public credit markets that private credit is priced relative to.)
Direct lending to investment-grade-adjacent companies at SOFR + 500 is a fundamentally different risk than mezzanine lending at SOFR + 1000 to a 7x-levered sponsor buyout. CLO AAA tranches are a different planet from CLO equity. BDCs vary enormously in portfolio quality. Don't make blanket statements — disaggregate by quality, seniority, and structure.
The 2008 drawdown occurred in a fundamentally different market (banks held loans on balance sheet; CLOs were smaller; private credit barely existed). The 2020 drawdown was V-shaped due to Fed intervention. Neither is a perfect template for the next drawdown. Adjust for: (a) the growth in private credit AUM since 2020, (b) the shift from bank lending to non-bank lending, (c) the proliferation of semi-liquid funds, and (d) the much larger CLO market.
The #1 mistake in drawdown positioning is sizing positions based on thesis conviction rather than loss tolerance. A 10% OTM put spread costs 3-6% of notional and can return 5-10x — but if wrong, the entire premium is lost. Position size should be determined by the maximum acceptable portfolio loss, not by how confident you are. Budget 3-5% of total portfolio for drawdown hedges; never more than 10%.
The biggest returns in credit come from buying the recovery, not from the initial short. The investors who made the most money in 2020 were those who (1) had shorts that paid off and then (2) redeployed that capital into distressed assets at trough prices. Build the exit plan for bearish positions AND the entry plan for opportunistic positions simultaneously. Don't just plan the drawdown — plan the cycle.
Private credit stress, high-yield widening, bank stock declines, and CLO repricing are correlated because they share common drivers (recession, defaults, rate stress) — but they are not the same trade. Each leg can diverge. A portfolio with shorts on BDCs, HYG, KRE, and CLO ETFs is not "diversified" — it's a concentrated bet on broad credit deterioration with highly correlated legs. Acknowledge this concentration and size accordingly.
The Gold Standard: A drawdown guide is publication-ready when every data point cites a source and date, every instrument recommendation has been verified as tradeable with sufficient liquidity, every historical return claim has been checked against actual index data, every strategy includes explicit risk management and exit criteria, the carry cost budget is modeled for 12+ months, and the disclaimer addresses derivatives suitability. If any of these are missing, the guide is not ready.
A tiered alert system for tracking private credit stress. Green = monitor. Yellow = prepare positions. Red = execute.
Normal market conditions. Maintain awareness. Accumulate low-cost options hedges when implied vol is cheap.
Early stress signals. Initiate positioning. Buy puts, establish CDS positions, prepare capital for post-drawdown deployment.
Full drawdown in progress. Maximize bearish exposure. Begin preparing capital for distressed purchasing. Monitor for capitulation signals.
Maximum stress. Begin unwinding bearish positions and deploying into distressed assets. This is where the biggest returns are made.
Build individual sub-guides in this order based on current market conditions, instrument accessibility, and data availability.
Phase 1 — Immediate (build now): BDC Sector Deep Dive (most accessible), HY/Loan ETF Options Playbook (most liquid), and CLO Market Monitor (most important leading indicator). These three cover the most actionable strategies with the best data availability.
Phase 2 — Next 30 days: CDS Index Strategy Guide (CDX HY, LCDX), Alternative Manager Equity Playbook (ARES, OWL, APO shorts), and Pair Trade Compendium (IG/HY, diversified/concentrated). Require more sophisticated execution infrastructure.
Phase 3 — As conditions develop: Distressed Debt Deployment Guide, Post-Drawdown Recovery Playbook, and Semi-Liquid Fund Redemption Analysis. These become relevant as the drawdown progresses — don't build prematurely.
Phase 4 — Continuous: Weekly Monitoring Dashboard and Catalyst Tracker. These should be living documents updated with each data release. Consider building as a web app rather than a static guide.
Every tradeable instrument relevant to private credit, CLO, and leveraged loan markets. 28 CLO ETFs, 8 loan ETFs, 12 HY ETFs, 45 BDCs, 20+ CEFs, CDS indices, credit futures, and inverse products. Data as of 7 April 2026.
| Ticker | Name | Issuer | AUM | Expense | Yield | Options |
|---|---|---|---|---|---|---|
| JAAA | Janus Henderson AAA CLO ETF | Janus Henderson | $26.7B | 0.20% | 5.14% | Yes |
| PAAA | PGIM AAA CLO ETF | PGIM | $8.3B | 0.19% | 5.03% | Limited |
| CLOA | iShares AAA CLO Active ETF | BlackRock | $2.0B | 0.20% | 5.12% | Limited |
| ACLO | TCW AAA CLO ETF | TCW | $469M | 0.20% | 4.86% | No |
| ICLO | Invesco AAA CLO FR Note ETF | Invesco | $440M | 0.19% | 5.35% | No |
| CLOX | Eldridge AAA CLO ETF | Eldridge | $262M | 0.20% | 5.07% | No |
| TRPA | Hartford AAA CLO ETF | Hartford | $101M | 0.24% | 5.37% | No |
| AAA | Alt Access First Priority CLO Bond ETF | Alt Access | $40M | 0.19% | 5.00% | No |
| FAAA | Fidelity AAA CLO ETF | Fidelity | $21M | 0.00%* | New | No |
| PCLO | Virtus Seix AAA Private Credit CLO ETF | Virtus | $19M | 0.29% | 5.40% | No |
| Ticker | Name | AUM | Expense | Yield | Tranches | Options |
|---|---|---|---|---|---|---|
| JBBB | Janus Henderson B-BBB CLO ETF | $1.11B | 0.47% | 7.23% | B-BBB | Yes |
| CLOZ | Eldridge/Panagram BBB-B CLO ETF | $589M | 0.50% | 7.84% | BBB-B | Limited |
| CLOI | VanEck CLO ETF | $1.31B | 0.36% | 5.49% | Broad | Limited |
| CLOB | VanEck AA-BB CLO ETF | $159M | 0.45% | 6.66% | AA-BB | No |
| NCLO | Nuveen AA-BBB CLO ETF | $150M | 0.26% | 5.90% | AA-BBB | No |
| BCLO | iShares BBB-B CLO Active ETF | $73M | 0.45% | 6.82% | BBB-B | No |
| PCMM | BondBloxx Private Credit CLO ETF | $201M | 0.68% | 6.80% | Pvt Credit | No |
| Ticker | Name | AUM | Expense | Yield | Type | Options |
|---|---|---|---|---|---|---|
| BKLN | Invesco Senior Loan ETF | $6.5B | 0.65% | 7.03% | Passive | Yes |
| SRLN | SPDR Blackstone Senior Loan ETF | $5.8B | 0.70% | 7.69% | Active | Yes |
| FTSL | First Trust Senior Loan Fund | $2.3B | 0.86% | ~7% | Active | Mod. |
| FLBL | Franklin Senior Loan ETF | $1.0B | 0.45% | ~7% | Active | Limited |
| LONZ | PIMCO Senior Loan Active ETF | $656M | 0.73% | ~7% | Active | No |
| BRLN | iShares Floating Rate Loan Active ETF | $500M+ | ~0.30% | ~7% | Active | No |
| USLN | iShares Broad USD Floating Rate Loan ETF | $23M | 0.40% | ~7% | Index (NEW Mar 2026) | No |
| Ticker | Name | AUM | Expense | Yield | Avg. Vol | Options |
|---|---|---|---|---|---|---|
| USHY | iShares Broad USD HY Corp Bond ETF | $23.8B | 0.08% | 6.92% | 11M/day | Yes |
| HYG | iShares iBoxx $ HY Corp Bond ETF | $16.5B | 0.49% | 5.86% | 42M/day | Yes — primary |
| SPHY | SPDR Portfolio HY Bond ETF | $10.0B | 0.05% | 7.35% | 5M/day | Yes |
| SHYG | iShares 0-5Y HY Corp Bond ETF | $7.4B | 0.30% | 7.06% | 3M/day | Yes |
| JNK | SPDR Bloomberg HY Bond ETF | $6.8B | 0.40% | 6.65% | 8M/day | Yes |
| SJNK | SPDR Bloomberg Short Term HY Bond ETF | $4.6B | 0.40% | 7.12% | 3M/day | Yes |
| ANGL | VanEck Fallen Angel HY Bond ETF | $3.0B | 0.25% | 6.38% | 1.5M/day | Yes |
| SJB | ProShares Short High Yield (INVERSE) | $147M | 0.95% | N/A | 500K/day | Limited |
| Ticker | Name | Mkt Cap | Yield | Strategy | Options |
|---|---|---|---|---|---|
| ARCC | Ares Capital Corporation | $13.0B | 10.6% | Senior secured, unitranche | Yes |
| BXSL | Blackstone Secured Lending | $5.5B | 13.0% | First lien senior secured | Yes |
| OBDC | Blue Owl Capital Corp | $5.4B | 13.9% | Senior secured direct lending | Yes |
| MAIN | Main Street Capital | $4.9B | 8.0% | Lower middle market | Yes |
| GBDC | Golub Capital BDC | $3.4B | 12.2% | First lien, one-stop | Mod. |
| FSK | FS KKR Capital Corp | $3.0B | 19.1% | Diversified + mezz | Yes |
| HTGC | Hercules Capital | $2.7B | 12.4% | Venture / tech lending | Yes |
| Ticker | Name | Mkt Cap | Yield | Strategy |
|---|---|---|---|---|
| TSLX | Sixth Street Specialty Lending | $1.7B | 11.3% | First lien, direct originated |
| CSWC | Capital Southwest | $1.4B | 11.4% | Lower middle market 1st lien |
| PSEC | Prospect Capital | $1.3B | 20.5% | Diversified; senior + mezz + RE |
| TRIN | Trinity Capital | $1.3B | 13.6% | Venture lending, equip. finance |
| MFIC | MidCap Financial (Apollo) | $1.1B | 10.7% | Senior secured |
| OCSL | Oaktree Specialty Lending | $1.0B | 13.6% | Senior secured |
| GSBD | Goldman Sachs BDC | $1.0B | 14.3% | First lien, unitranche |
| KBDC | Kayne Anderson BDC | $994M | 13.6% | Senior secured middle market |
| BBDC | Barings BDC | $873M | 12.5% | Senior secured, diversified |
| PFLT | PennantPark Floating Rate Capital | $830M | 14.7% | First lien floating rate |
| NMFC | New Mountain Finance | $812M | 15.9% | Defensive growth industries |
| BCSF | Bain Capital Specialty Finance | $810M | 15.6% | Senior secured, first lien |
| SLRC | SLR Investment Corp | $800M | 11.2% | Cash flow + ABL lending |
| CGBD | Carlyle Secured Lending | $775M | 15.0% | First lien, Carlyle-managed |
| FDUS | Fidus Investment Capital | $676M | 12.0% | Lower middle market + equity |
| Ticker | Name | Mkt Cap | Yield |
|---|---|---|---|
| CCAP | Crescent Capital BDC | $459M | 13.5% |
| GLAD | Gladstone Capital | $415M | 9.8% |
| CION | CION Investment | $356M | 17.1% |
| SAR | Saratoga Investment | $355M | 14.8% |
| TCPC | BlackRock TCP Capital | $316M | 20.3% |
| PNNT | PennantPark Investment | $293M | 21.4% |
| SCM | Stellus Capital Investment | $270M | 14.6% |
| RWAY | Runway Growth Finance | $243M | 20.8% |
| HRZN | Horizon Technology Finance | $212M | 29.7% |
| TPVG | TriplePoint Venture Growth | $206M | 18.1% |
| WHF | WhiteHorse Finance | $167M | 13.8% |
| OXSQ | Oxford Square Capital | $158M | 23.3% |
| GECC | Great Elm Capital | $73M | 23.2% |
| OFS | OFS Capital | $48M | 19.1% |
BDC ETFs: BIZD (VanEck BDC Income ETF, $1.44B AUM, ~10% yield, options available) and PBDC (Putnam BDC Income ETF, $247M). BIZD is the easiest way to get broad BDC sector short exposure via a single ticker.
| Ticker | Name | Focus | Disc/Prem | Yield | Leverage | Status |
|---|---|---|---|---|---|---|
| OXLC | Oxford Lane Capital | CLO equity | -16% | ~32% | 29.6% | Dist. cut 50% |
| ECC | Eagle Point Credit | CLO equity + debt | ~-15% | ~21% | 42.4% | Watch — at risk |
| EIC | Eagle Point Income | CLO junior debt | ~-10% | ~15% | Lower | Stable for now |
| XFLT | XAI Octagon FR & Alt Income | CLO equity + loans | ~-15% | ~18% | Credit facility | Watch |
| OCCI | OFS Credit Company | CLO equity | -33% | ~31% | Moderate | At risk of cut |
| CCIF | Carlyle Credit Income Fund | CLO equity | Deep disc. | ~31% | — | At risk |
| Ticker | Name | Manager | Focus |
|---|---|---|---|
| AFT | Apollo Senior Floating Rate Fund | Apollo | Senior secured floating rate |
| AIF | Apollo Tactical Income Fund | Apollo | Tactical credit, loans |
| BGT | BlackRock Floating Rate Income Trust | BlackRock | Floating rate loans |
| BSL | Blackstone Sr Floating Rate 2027 Term | Blackstone | Term fund; senior loans |
| FRA | Blackstone Senior Floating Rate Term | Blackstone | Senior loans |
| JFR | Nuveen Floating Rate Income Fund | Nuveen | Floating rate loans |
| JQC | Nuveen Credit Strategies Income | Nuveen | Loans + HY bonds |
| VTA | Invesco Credit Opportunities Fund | Invesco | Loans + credit |
| VVR | Invesco Senior Income Trust | Invesco | Senior loans |
| DSU | BlackRock Debt Strategies Fund | BlackRock | High yield + loans |
| Index | Constituents | Recovery | Roll | ~Spread | Access |
|---|---|---|---|---|---|
| CDX.NA.IG | 125 IG entities | Auction | Mar/Sep | ~60-80bps | ISDA / OTC |
| CDX.NA.HY | 100 HY entities | Auction | Mar/Sep | ~400-500bps | ISDA / OTC |
| LCDX | 100 first-lien loans | 70% fixed | Mar/Sep | ~250-350bps | ISDA / OTC |
| iTraxx Main | 125 European IG | Standard | Mar/Sep | ~60-80bps | ISDA / OTC |
| iTraxx Xover | 75 European sub-IG | Standard | Mar/Sep | ~350-450bps | ISDA / OTC |
| IQB (CME) | Bloomberg IG Index | Total return | Quarterly | Futures price | Listed — no ISDA |
| HYB (CME) | Bloomberg HY VLI | Total return | Quarterly | Futures price | Listed — no ISDA |
| Eurex IG/HY | iTraxx / Bloomberg | Total return | Quarterly | Futures price | Listed — no ISDA |
| Ticker | Name | Mkt Cap | Credit AUM | Credit % Fees | Drawdown from ATH | Options |
|---|---|---|---|---|---|---|
| APO | Apollo Global Management | $60.9B | $550B+ | 86% fee-earning | -39% | Yes, liquid |
| ARES | Ares Management | $25-34B | $407B | 66% fee-earning | -42% | Yes |
| OWL | Blue Owl Capital | $13.3B | $158B | 61% base fees | -61% | Yes |
| KKR | KKR & Co | $80.9B | $242B | 48% fee-earning | -44% | Yes, liquid |
| BX | Blackstone Inc | $138.5B | $355B | 32% (diversified) | -43% | Yes, very liquid |
| CG | Carlyle Group | $17.0B | $190B | ~43% | -25% | Yes |
$265B+ in combined alt manager market cap has been erased. Blue Owl is already limiting withdrawals in two funds. Apollo's 86% credit fee concentration makes it the highest-beta name to a private credit drawdown. Ares and Blue Owl are the purest short candidates for the pair trades in Section 03. Blackstone's diversification (RE, PE, insurance) provides relative insulation — the long leg of the pair.
Instrument Count Summary: 28 CLO ETFs ($42.3B AUM) · 8 Leveraged Loan ETFs ($17B+ AUM) · 12 Major HY Bond ETFs ($80B+ AUM) · 45 Publicly Traded BDCs ($60B+ combined mkt cap) · 20+ Credit CEFs · 5 CDS Indices · 3 Listed Credit Futures · 6 Alt Manager Stocks · 1 Inverse HY ETF · 2 BDC ETFs. Total tradeable universe: 130+ instruments across 10 categories.
This document is Volume II in a 12-volume series of institutional-grade market intelligence briefings covering private markets, alternative credit, insurance, banking, sovereign debt, and volatility strategies.